Form D · Biotechnology
Pinpoint Therapeutics Inc.
Philadelphia, PA · CIK 0001796645
Offering snapshot reported Dec 12, 2019 · SEC filing
- Reported sold
- $1M Offering amount: $1M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $1M Reported outside-investor minimum
- First sale
- Nov 26, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 12, 2019 | Initial | $1,000,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-355367
Source: Form D, filed Dec 12, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Christian Peters | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3401 Grays Ferry Avenue Building 176 1032
Philadelphia, PA, 19146
Philadelphia, PA, 19146